Trial intelligence / Profile preview

Intrathecal ephedrine with low-dose spinal bupivacaine for prevention of maternal supine hypotension during cesarean delivery

ChiCTR-IPR-14005477Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Shihezi University
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of ephedrine and bupivacaine in supine hypotensive syndrome (SHS) (4 arms), sponsored by The First Affiliated Hospital of Shihezi University. Primary endpoints: Maximum sensory block level, Time to complete block and 10 more. Started Jan 2014; status: recruiting.

02

Drugs

ephedrinebupivacaine
03

Conditions

supine hypotensive syndrome (SHS)

Beyond the preview

Go deeper on ChiCTR-IPR-14005477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-14005477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call